NCT00004643View on ClinicalTrials.gov

Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus

PHASE2CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

February 28, 1995

Conditions

Lupus Erythematosus, Systemic

Interventions

DRUG

cytarabine

All Listed Sponsors

collaborator

University of Michigan

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004643 - Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter